<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Pharm</journal-id><journal-id journal-id-type="iso-abbrev">Mol Pharm</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Molecular pharmaceutics</journal-title></journal-title-group><issn pub-type="ppub">1543-8384</issn><issn pub-type="epub">1543-8392</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12150280</article-id><article-id pub-id-type="pmcid-ver">PMC12150280.1</article-id><article-id pub-id-type="pmcaid">12150280</article-id><article-id pub-id-type="pmcaiid">12150280</article-id><article-id pub-id-type="manuscript-id">NIHMS2082723</article-id><article-id pub-id-type="pmid">40112155</article-id><article-id pub-id-type="doi">10.1021/acs.molpharmaceut.4c00984</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2082723</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2082723</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Computational Approaches for Predicting Drug Interactions with Human Organic Anion Transporter 4 (OAT4)</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Martinez-Guerrero</surname><given-names initials="L">Lucy</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="FN1" ref-type="author-notes">&#11832;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Vignaux</surname><given-names initials="PA">Patricia A.</given-names></name><xref rid="A3" ref-type="aff">c</xref><xref rid="FN1" ref-type="author-notes">&#11832;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Harris</surname><given-names initials="JS">Joshua S.</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lane</surname><given-names initials="TR">Thomas R.</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Urbina</surname><given-names initials="F">Fabio</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wright</surname><given-names initials="SH">Stephen H.</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ekins</surname><given-names initials="S">Sean</given-names></name><xref rid="A3" ref-type="aff">c</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cherrington</surname><given-names initials="NJ">Nathan J.</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>a</label>Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, 1703 E. Mabel, Tucson, AZ 85721, United States.</aff><aff id="A2"><label>b</label>Department of Physiology, College of Medicine, University of Arizona, 1200 E. University Blvd, Tucson, AZ 85724, United States.</aff><aff id="A3"><label>c</label>Collaborations Pharmaceuticals, Inc., 840 Main Campus Dr, Raleigh, NC 27606, United States.</aff><author-notes><corresp id="CR1"><label>*</label><email>cherrington@pharmacy.arizona.edu</email>; <email>sean@collaborationspharma.com</email></corresp><fn fn-type="equal" id="FN1"><label>&#11832;</label><p id="P1">L.M.G &amp; P.A.V contributed equally to this work</p></fn><fn id="FN3" fn-type="COI-statement"><p id="P47">Competing interests</p><p id="P48">SE is founder and owner of Collaborations Pharmaceuticals, Inc. TRL, FU, JSH and PAV are employees. All other authors have no conflicts of interest.</p></fn></author-notes><pub-date pub-type="ppub"><day>07</day><month>4</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>3</month><year>2025</year></pub-date><volume>22</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">490243</issue-id><fpage>1847</fpage><lpage>1858</lpage><pub-history><event event-type="nihms-submitted"><date><day>29</day><month>05</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>07</day><month>04</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-06-10 17:25:16.250"><day>10</day><month>06</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2082723.pdf"/><abstract id="ABS1"><p id="P2">Human Organic Anion Transporter 4 (OAT4) is predominantly expressed in the kidneys, particularly in the apical membrane of the proximal tubule cells. This transporter is involved in the renal handling of endogenous and exogenous organic anions (OA), making it an important transporter for drug-drug interactions (DDIs). To better understand OAT4-compound interactions, we generated single concentration (25 &#956;M) <italic toggle="yes">in vitro</italic> inhibition data for over 1400 small molecules against the uptake of the fluorescent OA 6-carboxyfluorescein (6-CF) in CHO cells. Several drugs exhibiting higher than 50% inhibition in this initial screen were selected to determine <inline-formula><mml:math id="M7" display="inline"><mml:mrow><mml:msub><mml:mtext>IC</mml:mtext><mml:mn>50</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> values against three structurally distinct OAT4 substrates: estrone sulfate (ES), ochratoxin A (OTA), and 6-CF. These <inline-formula><mml:math id="M8" display="inline"><mml:mrow><mml:msub><mml:mtext>IC</mml:mtext><mml:mn>50</mml:mn></mml:msub></mml:mrow></mml:math></inline-formula> values were then compared to the drug plasma concentration as per the 2020 FDA drug-drug interaction (DDI) guidance. Several screened compounds, including some not previously reported, emerged as novel inhibitors of OAT4. These data were also used to build machine learning classification models to predict the activity of potential OAT4 inhibitors. We compared multiple machine learning algorithms and data cleaning techniques to model these screening data and investigated the utility of conformal predictors to predict OAT4 inhibition of a leave-out set. These experimental and computational approaches allowed us to model diverse and unbalanced data to enable predictions for DDIs mediated by this transporter.</p></abstract><abstract id="ABS2" abstract-type="summary"><title>Significance</title><p id="P62">Understanding Human Organic Anion Transporter 4 (OAT4) is vital for assessing its impact on drug-drug interactions and renal drug handling. By screening a large library of compounds and identifying novel inhibitors, this study enhances our understanding of OAT4's role in drug disposition and potential DDIs. Additionally, employing machine learning models to predict OAT4 inhibition offers a powerful tool for improving drug safety and efficacy.</p></abstract><abstract id="ABS3" abstract-type="graphical"><title>Graphical Abstract</title><p id="P3">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="nihms-2082723-f0001.jpg"/>
</p><p id="P4">Created in BioRender. Martinez-Guerrero, L. (2025) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biorender.com/g97z346" ext-link-type="uri">https://BioRender.com/g97z346</ext-link></p></abstract><kwd-group><kwd>MegaTrans</kwd><kwd>Human Organic Anion Transporter 4 (OAT4)</kwd><kwd>Organic Anions (OA)</kwd><kwd>Drug-Drug Interactions (DDIs)</kwd><kwd>predictive Modeling</kwd><kwd>drug screening</kwd><kwd>Machine Learning</kwd><kwd>Conformal Predictors</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>